Concepedia

Richard Ghalie

RG

Statistics

Publications

40

Citations

1.8K

H-Index

26

Active since

1986

Affiliations

Rush University Medical Center(Current)

MEI Pharma (United States)

Cleveland Clinic

Indiana University – Purdue University Indianapolis

Presbyterian St. Luke's Medical Center

Richard Ghalie is an author at Rush University Medical Center specializing in medicine, hematology, and oncology.

Top concepts

MedicineHematologyHealthOncologyPharmacotherapyPharmacologyRadiation OncologyPathologyCancer ResearchImmunology

Publications per year

1986–2019

40

Publications

40

Phase I Study of Recombinant Human CD40 Ligand in Cancer Patients

Robert H. Vonderheide, Janice P. Dutcher, Jeanne E. Anderson et al. · Journal of Clinical Oncology · 2001 · 224 citations

Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma

Andres Forero, Paul L. Weiden, Julie M. Vose et al. · Blood · 2004 · 149 citations · Full text

Placebo-Controlled Phase III Trial of Patient-Specific Immunotherapy With Mitumprotimut-T and Granulocyte-Macrophage Colony-Stimulating Factor After Rituximab in Patients With Follicular Lymphoma

Arnold S. Freedman, Sattva S. Neelapu, Craig R. Nichols et al. · Journal of Clinical Oncology · 2009 · 138 citations · Full text

166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials

Sergio Giralt, William Bensinger, Mark Goodman et al. · Blood · 2003 · 120 citations · Full text

Phase 2, randomized, double‐blind study of pracinostat in combination with azacitidine in patients with untreated, higher‐risk myelodysplastic syndromes

Guillermo Garcia‐Manero, Guillermo Montalban‐Bravo, Jesús G. Berdeja et al. · Cancer · 2017 · 103 citations · Full text

1–5 of 40